World Gastroenterology Organisation Global Guideline Hepatitis B
Jordan J. Feld(University of Toronto), Anton LeMair(University Malaya Medical Centre), Isakov Va(Federal Research Centre of Nutrition and Biotechnology), Chau‐Ting Yeh(Chang Gung University), Harry L.A. Janssen(Erasmus MC), Jose D. Sollano(University of Santo Tomas), Man‐Fung Yuen(Queen Mary Hospital), Péter Ferenci, Zaigham Abbas(Ziauddin University), Stephen Locarnini(Victorian Infectious Diseases Reference Laboratory), Ono S(World Allergy Organization), Aamir Ghafoor Khan(Lady Reading Hospital), Seng Gee Lim(National University of Singapore), A Elewaut(World Allergy Organization), C Wendy Spearman(University of Cape Town)
Cited by 21
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
|New England Journal of Medicine|2014|907